Duchenne Muscular Dystrophy (DMD) is a devastating and incurable muscle-wasting disease which can affect boys. Symptoms tend to appear before the age of 6 years and life expectancy is usually ...

Muscular Dystrophy is a group of rare, genetic, progressive diseases that primarily affect the body’s muscles, causing them to weaken and deteriorate over time. The most common form of muscular ...

Agamree, an approved steroid treatment for Duchenne MD, will be sold in Turkey by GEN, per an agreement with Santhera.

University of Manchester scientists have mapped the mutations in the tiny protein chains that cause a subtype of muscular ...

Duchenne muscular dystrophy (DMD) is a severe, X‐linked neuromuscular disorder that arises from mutations in the dystrophin gene, leading to progressive muscle wasting and compromised function.

Managing osteoporosis and bone health in Duchenne muscular dystrophy occurs in a high-risk environment for fractures due to ...

Ann & Robert H.Lurie Children’s Hospital of Chicago treated its first Duchenne muscular dystrophy patient on March 27, 2024with ELEVIDYS (received U.S. Food and Drug Administration (FDA ...

Parent Project Muscular Dystrophy fights to end Duchenne. We accelerate research, raise our voices to impact policy, demand optimal care for every single family, and strive to ensure access to ...

The Duchenne muscular dystrophy market is witnessing steady growth driven by advancements in gene therapies, exon-skipping drugs, and corticosteroid alternatives. Increasing diagnosis rates ...

The Duchenne muscular dystrophy market is witnessing steady growth driven by advancements in gene therapies, exon-skipping drugs, and corticosteroid alternatives. Increasing diagnosis rates, rising ...